Clinical and scientific impact of National Cancer Institute: Sponsored clinical trial network group treatment trials

被引：0

作者：

Unger, J. M. ^{[1
]}

LeBlanc, M. ^{[1
]}

Bertagnolli, M. ^{[2
]}

Wolmark, N. ^{[3
]}

Curran, W. J. ^{[4
]}

O'Dwyer, P. J. ^{[5
]}

Schnall, M. D. ^{[6
]}

Mannel, R. S. ^{[7
]}

Costantino, J. P. ^{[8
]}

Gray, R. J. ^{[9
]}

Zhao, F. ^{[9
]}

Hong, F. ^{[10
]}

Bah, M. ^{[11
]}

Vaidya, R. ^{[11
]}

Blanke, C. D. ^{[12
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA

[2] Brigham & Womens Hosp, Surg Oncol, 75 Francis St, Boston, MA 02115 USA

[3] Allegheny Gen Hosp, Allegheny Canc Ctr, Pittsburgh, PA 15212 USA

[4] Emory Univ, Winship Canc Inst, Med Dept, Atlanta, GA 30322 USA

[5] Univ Penn, Med Oncol, Franklin Bldg, Philadelphia, PA 19104 USA

[6] Verwoerd Hosp, Med Oncol, Pretoria, South Africa

[7] Stephenson Canc Ctr, Med Oncol, Oklahoma City, OK USA

[8] Univ Pittsburgh, Biostat, Pittsburgh, PA USA

[9] Dana Farber Canc Inst, Biostat, Boston, MA 02115 USA

[10] Harvard Univ, Biostat, Boston, MA 02115 USA

[11] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA

[12] SWOG Canc Res Network, Med Dept, Portland, OR USA

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/j.annonc.2021.08.832

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1503O

引用

页码：S1102 / S1103

页数：2

共 50 条

[11] Cancer patient care in clinical trials sponsored by the National Cancer Institute: What does it cost?
Brown, ML
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (10) : 818 - 819
[12] Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies
Unger, Joseph M.
Hershman, Dawn L.
Osarogiagbon, Raymond U.
Gothwal, Anirudh
Anand, Seerat
Dasari, Arvind
Overnman, Michael
Loree, Jonathan M.
Raghav, Kanwal
CANCER RESEARCH, 2020, 80 (16)
[13] Early closure of clinical trials: The experience of the National Cancer Institute of Canada Clinical Trials Group.
Parulekar, W.
Pater, J. L.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 314S - 314S
[14] THE INSTITUTE OF MEDICINE, THE NATIONAL CANCER INSTITUTE, AND CLINICAL TRIALS
Cox, James D.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1285 - 1286
[15] The National Cancer Institute's Experimental Therapeutics Clinical Trials Network
Ivy, S. Percy
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (03) : 144 - 146
[16] A National Cancer Clinical Trials Network: Recommendations From the Institute of Medicine
Nass, Sharyl J.
Balogh, Erin
Mendelsohn, John
AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (05) : 382 - 391
[17] Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies
Unger, Joseph M.
Hershman, Dawn L.
Osarogiagbon, Raymond U.
Gothwal, Anirudh
Anand, Seerat
Dasari, Arvind
Overman, Michael
Loree, Jonathan M.
Raghav, Kanwal
JNCI CANCER SPECTRUM, 2020, 4 (04)
[18] Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute - Sponsored clinical trials networks
Sloan, Jeff A.
Berk, Lawrence
Roscoe, Joseph
Fisch, Michael J.
Shaw, Edward G.
Wyatt, Gwen
Morrow, Gary R.
Dueck, Amylou C.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (32) : 5070 - 5077
[19] Benchmarks of success in radiotherapy vs systemic therapy: National Clinical Trials Network (NCTN) randomized controlled trials sponsored by the National Cancer Institute (NCI)
Sanford, Nina N.
Shi, Qian
Hein, David M.
Hall, William A.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025,
[20] CLINICAL COOPERATIVE TRIALS OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS-GROUP BREAST-CANCER-SITE-GROUP
PRITCHARD, KI
CANCER, 1994, 74 (03) : 1150 - 1155

← 1 2 3 4 5 →